Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis

J Dermatol. 2011 Sep;38(9):859-63. doi: 10.1111/j.1346-8138.2011.01214.x. Epub 2011 May 4.

Abstract

A dose of 60 units (U) of botulinum toxin type A (BT-A) has been confirmed to have efficacy for patients with palmoplantar hyperhidrosis. However, the effectiveness of this dose is limited in severe cases defined as sweat production of 2 mg/cm(2) per min or more (measured by the ventilated capsule method) and a Hyperhidrosis Disease Severity Scale (HDSS) grade of 3 or 4. An increased dose of 90 U of BT-A was found to reduce sweating for approximately 7 months. In a comparison of patients with sweat production of more than 2.5 mg/cm(2) per min and an HDSS grade of 4 and patients with sweat production of 2.5 mg/cm(2) per min or less and an HDSS grade of 3, there was no difference in the reduction of sweat production at 5 months, but the duration of the reduced sweating was shorter for the former group. This suggests that there are limits to the efficacy of BT-A for severe forms of the disease with sweat production of more than 2.5 mg/cm(2) per mL.

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Hand
  • Humans
  • Hyperhidrosis / drug therapy*
  • Hyperhidrosis / physiopathology
  • Injections, Intradermal
  • Male
  • Severity of Illness Index
  • Sweating / drug effects
  • Time Factors
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A